Advent leads $70m second round financing

The UK private equity firm has led a $70m investment in US pharmaceuticals company Infinity Pharmaceuticals.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this